OyaGen Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OyaGen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10912
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OyaGen Inc (OyaGen) is a biotechnology company that discovers, develops and commercializes novel pharmaceutical therapies. The company offers viral infectivity factor Dimerization Antagonist, Vif Interaction with APOBEC3G, Vif dependent polyubiquitination of APOBEC3G and APOBEC3G activators. It utilizes RNA editing and DNA editing enzymes to develop pharmaceutical therapies. OyaGen provides therapeutics for the treatment of diseases caused by human immunodeficiency virus. The company’s RNA editing and DNA editing enzymes are endogenous cellular proteins which chemically alter RNA or DNA molecules and change the genetic code. OyaGen is headquartered in Henrietta, New York, the US.

OyaGen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OyaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OyaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OyaGen Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
OyaGen Raises USD0.3 Million in Venture Financing 10
OyaGen Raises US$0.1 Million In Venture Financing 11
Oyagen Raises US$2 Million In Venture Financing 12
OyaGen Inc – Key Competitors 13
OyaGen Inc – Key Employees 14
OyaGen Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
OyaGen Inc, Pharmaceuticals & Healthcare, Key Facts 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OyaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OyaGen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
OyaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OyaGen Raises USD0.3 Million in Venture Financing 10
OyaGen Raises US$0.1 Million In Venture Financing 11
Oyagen Raises US$2 Million In Venture Financing 12
OyaGen Inc, Key Competitors 13
OyaGen Inc, Key Employees 14

List of Figures
OyaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OyaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[OyaGen Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Odebrecht S.A.:企業の戦略・SWOT・財務分析
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • ULURU Inc (ULUR)-医療機器分野:企業M&A・提携分析
    Summary ULURU Inc (ULURU) is a developer and commercializer of wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU’s OraDisc is a polymer …
  • FuelCell Energy Inc (FCEL):電力:M&Aディール及び事業提携情報
    Summary FuelCell Energy Inc (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. The company offers proprietary fuel cell products based on carbonate fuel cell technology. …
  • Novan Inc (NOVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Novan Inc (Novan) is a clinical-stage pharmaceutical company that develops nitric oxide therapies for the treatment of dermatological and oncovirus-mediated diseases. The company’s pipeline products are being developed for the treatment of acne vulgaris; genital warts; for onychomycosis and …
  • Albireo Pharma Inc (ALBO):企業の財務・戦略的SWOT分析
    Albireo Pharma Inc (ALBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • A-Sonic Aerospace Limited:企業の戦略・SWOT・財務分析
    A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report Summary A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Amplia Therapeutics Ltd (ATX):製薬・医療:M&Aディール及び事業提携情報
    Summary Amplia Therapeutics Ltd (Amplia Therapeutics), formerly Innate Therapeutics Ltd, is a pharmaceutical company with focus on the development of focal adhesion kinase (FAK) inhibitors for the treatment of cancer and fibrosis. Its lead drug candidate, AMP945, is a small molecule targeting focal …
  • Steel Reef Infrastructure Corp-石油・ガス分野:企業M&A・提携分析
    Summary Steel Reef Infrastructure Corp (Steel Reef) is a mid-stream company that focuses on long-term returns through investments in small to midsized infrastructure with focus on the Western Canadian Sedimentary Basin. The company carries out the construction, operation and optimization of oil and …
  • Reed’s, Inc.:企業の戦略・SWOT・財務情報
    Reed's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Reed's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ayala Land Inc:戦略・SWOT・企業財務分析
    Ayala Land Inc - Strategy, SWOT and Corporate Finance Report Summary Ayala Land Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • FTS International Services LLC:企業の戦略的SWOT分析
    FTS International Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • American Axle & Manufacturing Holdings, Inc.
    American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Berry Global Group Inc:企業の戦略・SWOT・財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fibrocell Science Inc (FCSC):企業の財務・戦略的SWOT分析
    Fibrocell Science Inc (FCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Andhra Pradesh Power Generation Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary Andhra Pradesh Power Generation Corporation Limited (APGENCO) is a state-owned electricity utility that that conducts the generation, operation, maintenance and execution of energy projects. The company owns, operates, and maintains thermal, hydel and wind power plants. APGENCO also undertak …
  • Airbus Group SE:企業の戦略・SWOT・財務情報
    Airbus Group SE - Strategy, SWOT and Corporate Finance Report Summary Airbus Group SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Parion Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Parion Sciences Inc (Parion Sciences) is a development stage company that provides research, development and commercialization of treatments to improve patient’s innate mucosal surface defenses. The company’s pipeline products include P-1037, a clinical stage ENaC blocker for pulmonary disea …
  • Alabama Municipal Electric Authority:企業の戦略的SWOT分析
    Alabama Municipal Electric Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Heidelberg Pharma AG (WL6)-製薬・医療分野:企業M&A・提携分析
    Summary Heidelberg Pharma AG(Heidelberg Pharma) formerly known as Wilex AG is a biopharmaceutical company with a focus on cancer. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. It develops products based on and small mo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆